Cited by 602HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.

Open access

Liu, Albert Y., Cohen, Stephanie E., Vittinghoff, Eric, Anderson, Peter L., Doblecki-Lewis, Susanne, Bacon, Oliver, Chege, Wairimu, Postle, Brian S., Matheson, Tim, Amico, K. Rivet, Liegler, Teri, Rawlings, M. Keith, Trainor, Nikole, Blue, Robert Wilder, Estrada, Yannine, Coleman, Megan E., Cardenas, Gabriel, Feaster, Daniel J., Grant, Robert, Philip, Susan S., Elion, Richard, Buchbinder, Susan, Kolber, Michael A.·2016·JAMA Internal Medicine

DOI 10.1001/jamainternmed.2015.4683PMC PMC5042323

Open this paper in CoChat — free account Open PDF

Abstract

IMPORTANCE: Several randomized clinical trials have demonstrated the efficacy of preexposure prophylaxis (PrEP) in preventing human immunodeficiency virus (HIV) acquisition. Little is known about adherence to the regimen, sexual practices, and overall effectiveness when PrEP is implemented in clinics that treat sexually transmitted infections (STIs) and community-based clinics serving men who have sex with men (MSM). OBJECTIVE: To assess PrEP adherence, sexual behaviors, and the incidence of STIs and HIV infection in a cohort of MSM and transgender women initiating PrEP in the United States. DESIGN, SETTING, AND PARTICIPANTS: Demonstration project conducted from October 1, 2012, through February 10, 2015 (last date of follow-up), among 557 MSM and transgender women in 2 STI clinics in San Francisco, California, and Miami, Florida, and a community health center in Washington, DC. Data were analyzed from December 18, 2014, through August 8, 2015. INTERVENTIONS: A combination of daily, oral tenofovir disoproxil fumarate and emtricitabine was provided free of charge for 48 weeks. All participants received HIV testing, brief client-centered counseling, and clinical monitoring. MAIN OUTCOMES AND MEASURES: Concentrations of tenofovir diphosphate in dried blood spot samples, self-reported numbers of anal sex partners and episodes of condomless receptive anal sex, and incidence of STI and HIV acquisition. RESULTS: Overall, 557 participants initiated PrEP, and 437 of these (78.5%) were retained through 48 weeks. Based on the findings from the 294 participants who underwent measurement of tenofovir diphosphate levels, 80.0% to 85.6% had protective levels (consistent with ≥4 doses/wk) at follow-up visits. African American participants (56.8% of visits; P = .003) and those from the Miami site (65.1% of visits; P < .001) were less likely to have protective levels, whereas those with stable housing (86.8%; P = .02) and those reporting at least 2 condomless anal sex partners in the past 3 months (88.6%; P = .01) were more likely to have protective levels. The mean number of anal sex partners declined during follow-up from 10.9 to 9.3, whereas the proportion engaging in condomless receptive anal sex remained stable at 65.5% to 65.6%. Overall STI incidence was high (90 per 100 person-years) but did not increase over time. Two individuals became HIV infected during follow-up (HIV incidence, 0.43 [95% CI, 0.05-1.54] infections per 100 person-years); both had tenofovir diphosphate levels consistent with fewer than 2 doses/wk at seroconversion. CONCLUSIONS AND RELEVANCE: The incidence of HIV acquisition was extremely low despite a high incidence of STIs in a large US PrEP demonstration project. Adherence was higher among those participants who reported more risk behaviors. Interventions that address racial and geographic disparities and housing instability may increase the impact of PrEP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2015.4683

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000093487.78664.3c · Cited by 6,359
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citation
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
Preexposure Prophylaxis for HIV Infection among African Women
Damme, L. V., Corneli, A. L., Ahmed, K., Agot, K. E., Lombaard, J. J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R. N., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,633
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapía, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,229
Regression models for ordinal responses: a review of methods and applications
Ananth, C. V. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.6.1323 · Cited by 594
Diagnoses of HIV infection in the United States and dependent areas, 2012
Siddiqi, A.-E.-A., Cohen, S. M., Johnson, A. S., Hu, X., Li, J., Patala, A., Wu, B., Guo, X., Dasari, S. R., Hall, I., et al. (2014) · Cited by 429

Show all 46 references

Research works printed but not linked: 6

[4]McCormack S Dunn D Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study [Abstract 22LB] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015
[5]Molina JM Capitant C Spire B On Demand PrEP With Oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial [Abstract 24LB] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015 2015
[40]Liu A Developing and Implementing a Mobile Health (mHealth) Adherence Support System for HIV-Uninfected Men who have Sex with Men (MSM) Taking Pre-Exposure Prophylaxis (PrEP): The iText Study 8th International Conference on HIV Treatment and Prevention Adherence; [AB 229] Miami, FL June 2-4, 2013
[42]Scott H Vittinghoff E Irvin R Sex Pro: A Personalized HIV Risk Assessment Tool for Men Who Have Sex With Men [Abstract 1017] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015
[43]Vallabhaneni S Hartogensis W Sheon N Harnessing mobile health technology in HIV research: a pilot study utilizing a smartphone-based daily-diary app to collect event-level sexual activity data [Abstract TUPE358] 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention 2013 Kuala Lampur, Malaysia
[46]Cohen SE Vittinghoff E Doblecki-Lewis S Response to “Race and the public health impact potential of PrEP in the United States” J Acquir Immune Defic Syndr 2015 PMC4558271 26049284

Sorted by citations

Items 201–300 of 599

Suboptimal HIV Pre-exposure Prophylaxis Awareness and Willingness to Use Among Women Who Use Drugs in the United States: A Systematic Review and Meta-analysis
Zhang, C., McMahon, J. M., Simmons, J., Brown, L. L., Nash, R., & Liu, Y. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02573-x · Cited by 35
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?
Parikh, U. M., & Mellors, J. W. (2022) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000746 · Cited by 34
Substance Use and Adherence to HIV Pre-Exposure Prophylaxis in Studies Enrolling Men Who Have Sex with Men and Transgender Women: A Systematic Review
Gebru, N. M., Canidate, S. S., Liu, Y., Schaefer, S. E., Pavila, E., Cook, R. L., & Leeman, R. F. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03948-3 · Cited by 33
Vaccine value profile for Neisseria gonorrhoeae
Lyu, Y., Choong, A., Chow, E. P. F., Seib, K. L., Marshall, H. S., Unemo, M., de Voux, A., Wang, B., Miranda, A. E., Gottlieb, S. L., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.01.053 · Cited by 35
Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV — CDC Recommendations, United States, 2025
Tanner, M. R., O’Shea, J., Byrd, K. M., Johnston, M., Dumitru, G. G., Le, J. N., Lale, A., Byrd, K. K., Cholli, P. A., Kamitani, E., et al. (2025) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7401a1 · Cited by 33
Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men
Roberts, C. P., & Klausner, J. D. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1236683 · Cited by 34
A modeling framework to inform preexposure prophylaxis initiation and retention scale-up in the context of ‘Getting to Zero’ initiatives
Khanna, A. S., Schneider, J. A., Collier, N. T., Ozik, J., Issema, R. S., Paola, A. D., Skwara, A., Ramachandran, A., Webb, J., Brewer, R., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002290 · Cited by 33
HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers
Zhang, H. L., Rhea, S. K., Hurt, C. B., Mobley, V., Swygard, H., Seña, A. C., & McKellar, M. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001546 · Cited by 32
Current levels of gonorrhoea screening in MSM in Belgium may have little effect on prevalence: a modelling study
Buyze, J., Berghe, W. V., Hens, N., & Kenyon, C. R. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818000092 · Cited by 32
Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults’ Perspectives
Sun, C. J., Anderson, K. M., Bangsberg, D. R., Toevs, K., Morrison, D., Wells, C., Clark, P., & Nicolaidis, C. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-04850-w · Cited by 33
Tenofovir alafenamide use in pregnant and lactating women living with HIV
Eke, A. C., Brooks, K. M., Gebreyohannes, R. D., Sheffield, J. S., Dooley, K. E., & Mirochnick, M. H. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1738384 · Cited by 32
Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.
Tang, E. C., Vittinghoff, E., Philip, S. S., Doblecki-Lewis, S., Bacon, O., Chege, W., Coleman, M. E., Elion, R., Buchbinder, S., Kolber, M. A., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002522 · Cited by 31
Sociodemographic and Clinical Factors Associated With Increasing Bacterial Sexually Transmitted Infection Diagnoses in Men Who Have Sex With Men Accessing Care at a Boston Community Health Center (2005–2015)
Mayer, K. H., Maloney, K. M., Levine, K., King, D. S., Grasso, C., Krakower, D., Rosenberg, E. S., & Boswell, S. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx214 · Cited by 32
Increasing prevalence of self-reported HIV preexposure prophylaxis use in published surveys
Kamitani, E., Wichser, M. E., Adegbite, A. H., Mullins, M. M., Johnson, W. D., Crouch, P.-C., & Sipe, T. A. (2018) · AIDS · doi:10.1097/qad.0000000000001983 · Cited by 31
Brief Report: Discrepancies Between Self-Reported Adherence and a Biomarker of Adherence in Real-World Settings
Hebel, S., Kahn-Woods, E., Malone-Thomas, S., McNeese, M., Thornton, L., Sukhija-Cohen, A. C., Patani, H., Engeran-Cordova, W., & Daughtridge, G. W. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002486 · Cited by 31
Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old
John, S. A., Zapata, J. P., Dang, M., Pleuhs, B., O’Neil, A. M., Hirshfield, S., Walsh, J. L., Petroll, A. E., & Quinn, K. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-32014-8 · Cited by 31
The preexposure prophylaxis revolution
Elion, R., & Coleman, M. E. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000222 · Cited by 30
Pre-exposure Prophylaxis for HIV Prevention: Why, What, Who and How
Davies, O., Ustianowski, A., & Fox, J. (2016) · Infectious Diseases and Therapy · doi:10.1007/s40121-016-0128-8 · Cited by 29
Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling Study
Goodreau, S. M., Hamilton, D. T., Jenness, S. M., Sullivan, P. S., Valencia, R., Wang, L. Y., Dunville, R. L., Barrios, L. C., & Rosenberg, E. S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.09.023 · Cited by 31
Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis
Rozhnova, G., Heijne, J. C. M., Bezemer, D., van Sighem, A., Presanis, A. M., Angelis, D. D., & Kretzschmar, M. (2018) · AIDS · doi:10.1097/qad.0000000000002050 · Cited by 30
Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study
Hightow‐Weidman, L., Magnus, M., Beauchamp, G. G., Hurt, C. B., SHOPTAW, S. J., Emel, L., Piwowar‐Manning, E., Mayer, K. H., Nelson, L. E., Wilton, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1141 · Cited by 30
Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP
Wilton, J., Mishra, S., & Tan, D. H. S. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001472 · Cited by 30
Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project
Doblecki‐Lewis, S., Liu, A., Feaster, D. J., Cohen, S. E., Elion, R., Bacon, O., Coleman, M. E., Cardenas, G. A., & Kolber, M. A. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001724 · Cited by 30
PrEP Eligibility and Interest Among Clinic- and Community-Recruited Young Black Women in Atlanta, Georgia, USA
Sales, J. M., Steiner, R. J., Brown, J. L., Swartzendruber, A. L., Patel, A. S., & Sheth, A. N. (2018) · Current HIV Research · doi:10.2174/1570162x16666180731143756 · Cited by 30
Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network
Spinelli, M. A., Scott, H. M., Vittinghoff, E., Liu, A., Morehead-Gee, A., Gonzalez, R., & Buchbinder, S. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy099 · Cited by 29
Living While Black, Gay, and Poor: The Association of Race, Neighborhood Structural Disadvantage, and Prep Utilization Among a Sample of Black Men Who Have Sex With Men in the Deep South
Burns, P., Hall, C. D. X., Poteat, T., Mena, L. A., & Wong, F. Y. (2021) · AIDS Education and Prevention · doi:10.1521/aeap.2021.33.5.395 · Cited by 30
HIV Preexposure Prophylaxis and Condomless Sex: Disentangling Personal Values From Public Health Priorities
Calabrese, S. K., Underhill, K., & Mayer, K. H. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303966 · Cited by 28
Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS
del Romero, J., & Soriano, V. (2018) · Aids Reviews · doi:10.24875/aidsrev.18000034 · Cited by 28
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity
Stewart, J. C., & Baeten, J. M. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00527-4 · Cited by 28
Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States
Adams, J. L., Shelley, K., & Nicol, M. R. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2240 · Cited by 27
First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabine
Siguier, M., Mera, R. M., Pialoux, G., Ohayon, M., Cotte, L., Valin, N., Ghosn, J., Cua, É., Pintado, C., Chas, J., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz220 · Cited by 27
Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States
Elion, R., Kabiri, M., Mayer, K. H., Wohl, D. A., Cohen, J. T., Beaubrun, A. C., & Altice, F. L. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16091592 · Cited by 26
Differences in sexually transmitted infection risk comparing preexposure prophylaxis users and propensity score matched historical controls in a clinic setting
Montaño, M. A., Dombrowski, J. C., Dasgupta, S., Golden, M. R., Manhart, L. E., Barbee, L. A., Duerr, A. C., & Khosropour, C. M. (2019) · AIDS · doi:10.1097/qad.0000000000002281 · Cited by 27
Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool
Reyniers, T., Hoornenborg, E., Vuylsteke, B., Wouters, K., & Laga, M. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052699 · Cited by 29
Patterns of PrEP Retention Among HIV Pre-exposure Prophylaxis Users in Baltimore City, Maryland
Wu, L., Schumacher, C. M., Chandran, A., Fields, E. L., Price, A., Greenbaum, A. H., Jennings, J. M., & Collaborative, T. I. P. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002506 · Cited by 26
Development of an Agent-Based Model to Investigate the Impact of HIV Self-Testing Programs on Men Who Have Sex With Men in Atlanta and Seattle
Luo, W. P., Katz, D. A., Hamilton, D. T., Mckenney, J. L., Jenness, S. M., Goodreau, S. M., Stekler, J. D., Rosenberg, E. S., Sullivan, P. S., & Cassels, S. L. (2018) · JMIR Public Health and Surveillance · doi:10.2196/publichealth.9357 · Cited by 25
Design and Delivery of Real-Time Adherence Data to Men Who Have Sex with Men Using Antiretroviral Pre-exposure Prophylaxis via an Ingestible Electronic Sensor
Chai, P. R., Goodman, G. R., Bustamante, M. J., Mendez, L., Mohamed, Y., Mayer, K. H., Boyer, E. W., Rosen, R. K., & O’Cleirigh, C. M. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-03082-y · Cited by 26
Chlamydia trachomatis transmission between the oropharynx, urethra and anorectum in men who have sex with men: a mathematical model
Xu, X., Chow, E. P. F., Ong, J. J., Hoebe, C. J. P. A., Zou, Z., Hocking, J. S., Fairley, C. K., & Zhang, L. (2020) · BMC Medicine · doi:10.1186/s12916-020-01796-3 · Cited by 25
Latent Classes of Sexual Positioning Practices and Sexual Risk Among Men Who Have Sex with Men in Paris, France
Dangerfield, D. T., Carmack, C. C., Gilreath, T. D., & Duncan, D. T. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2267-2 · Cited by 24
Leveling Up PrEP: Implementation Strategies at System and Structural Levels to Expand PrEP Use in the United States
Rutstein, S. E., & Muessig, K. E. (2024) · Current HIV/AIDS Reports · doi:10.1007/s11904-024-00697-x · Cited by 29
Syndemics among individuals enrolled in the PrEP Brasil Study
Boni, R. B. D., Machado, I. K., de Vasconcellos, M. T. L., Hoagland, B., Kallas, E. G., Madruga, J. V., Fernandes, N. M., Cerqueira, N. B., Moreira, R. I., Goulart, S. P., et al. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.12.016 · Cited by 23
Open pilot trial of a brief motivational interviewing-based HIV pre-exposure prophylaxis intervention for men who have sex with men: preliminary effects, and evidence of feasibility and acceptability
Moitra, E., van den Berg, J. J., Sowemimo-Coker, G., Chau, S., Nunn, A. S., & Chan, P. A. (2019) · AIDS Care · doi:10.1080/09540121.2019.1622644 · Cited by 24
Models of HIV Pre-Exposure Prophylaxis Care Used in Title X Family Planning Clinics in the Southern U.S.
Piper, K. N., Escoffery, C., Sales, J. M., & Sheth, A. N. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.10.005 · Cited by 24
Human papillomavirus vaccination in men who have sex with men – what will be required by 2020 for the same dramatic changes seen in heterosexuals
Fairley, C. K., Zou, H., Zhang, L., & Chow, E. P. F. (2016) · Sexual Health · doi:10.1071/sh16067 · Cited by 24
Decisional Balance and Contemplation Ladder to Support Interventions for HIV Pre-Exposure Prophylaxis Uptake and Persistence
John, S. A., Rendina, H. J., Starks, T. J., Grov, C., & Parsons, J. T. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2018.0136 · Cited by 24
Rectal Infection WithNeisseria gonorrhoeaeandChlamydia trachomatisin Men in the United States
Tao, G., Hoover, K. W., Nye, M. B., Peters, P. J., Gift, T. L., Peruvemba, R., & Body, B. A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw594 · Cited by 23
Prevención y tratamiento de las infecciones de transmisión sexual en personas con alto riesgo, incluyendo pacientes infectados por el VIH
del Romero, J., Garcia, J. N., & Espasa, M. (2018) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2018.11.008 · Cited by 24
Behavioral Interventions to Enhance PrEP Uptake Among Black Men Who Have Sex With Men
Remy, L. M., & Enriquez, M. (2019) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000015 · Cited by 23
Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles
Goodman‐Meza, D., Beymer, M. R., Kofron, R., Amico, K. R., Psaros, C., Bushman, L. R., Anderson, P. L., Bolan, R., Jordan, W. C., Rooney, J. F., et al. (2019) · AIDS Care · doi:10.1080/09540121.2019.1595523 · Cited by 23
HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya
Ortblad, K. F., Kearney, J. E., Mugwanya, K. K., Irungu, E., Haberer, J. E., Barnabas, R. V., Donnell, D. J., Mugo, N., Baeten, J. M., & Ngure, K. (2019) · Trials · doi:10.1186/s13063-019-3521-2 · Cited by 23
Vulnerable Periods: Characterizing Patterns of Sexual Risk and Substance Use During Lapses in Adherence to HIV Pre-exposure Prophylaxis Among Men Who Have Sex With Men
Wray, T. B., Chan, P. A., Kahler, C. W., Simpanen, E. M., Liu, T., & Mayer, K. H. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001914 · Cited by 23
Modeling the Impact of PrEP Programs for Adolescent Sexual Minority Males Based on Empirical Estimates for the PrEP Continuum of Care
Hamilton, D. T., Rosenberg, E. S., Sullivan, P. S., Wang, L. Y., Dunville, R. L., Barrios, L. C., Aslam, M. V., Mustanski, B. S., & Goodreau, S. M. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.06.041 · Cited by 22
Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the “PrEP as a bridge to ART” strategy
on behalf of the Partners Demonstration Project Team, Musinguzi, N., Kidoguchi, L., Mugo, N., Ngure, K., Katabira, E. T., Celum, C., Baeten, J. M., Heffron, R. A., & Haberer, J. E. (2020) · BMC Public Health · doi:10.1186/s12889-020-09712-3 · Cited by 22
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083
Mitchell, K. M., Boily, M., Hanscom, B. S., Moore, M., Todd, J., Paz‐Bailey, G., Wejnert, C., Liu, A., Donnell, D. J., Grinsztejn, B. G. J., et al. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100416 · Cited by 22
Development of a targeted educational intervention to increase pre-exposure prophylaxis uptake among cisgender men and transgender individuals who have sex with men and use methamphetamine in Seattle (WA, USA)
McMahan, V., Martin, A., Garske, L., Violette, L. R., Andrasik, M. P., Baeten, J. M., Banta‐Green, C. J., & Stekler, J. D. (2019) · Sexual Health · doi:10.1071/sh18060 · Cited by 22
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing
Spinelli, M. A., Glidden, D. V., Anderson, P. L., Gandhi, M., Cohen, S. E., Vittinghoff, E., Coleman, M. E., Scott, H. M., Bacon, O., Elion, R., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002005 · Cited by 22
Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM)
Owens, C., Hubach, R. D., Lester, J. N., Williams, D. M., Voorheis, E., Reece, M., & Dodge, B. (2020) · AIDS Care · doi:10.1080/09540121.2020.1757021 · Cited by 22
Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE
Vaccher, S. J., Grulich, A. E., McAllister, J., Templeton, D. J., Bloch, M. T., McNulty, A. M., Holden, J., Poynten, I. M., Prestage, G., & Zablotska, I. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012179 · Cited by 21
Brief Report: Cocaine Use and Pre-exposure Prophylaxis: Adherence, Care Engagement, and Kidney Function
Hojilla, J. C., Satre, D. D., Glidden, D. V., McMahan, V., Gandhi, M., Defechereux, P. A., Guanira, J. V., Mehrotra, M., Grant, R. M., & Carrico, A. W. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001972 · Cited by 21
Perceived Risk of HIV Infection and Acceptability of PrEP among Men Who Have Sex with Men in Brazil
Soares, F., Magno, L., da Silva, L. A. V., Guimarães, M. D. C., Leal, A. F., Knauth, D. R., Veras, M. A. D. S. M., de Brito, A. M., Kendall, C., Kerr, L. R. F. S., et al. (2022) · Archives of Sexual Behavior · doi:10.1007/s10508-022-02342-3 · Cited by 21
Increasing Participation in a TelePrEP Program for Sexual and Gender Minority Adolescents and Young Adults in Louisiana: Protocol for an SMS Text Messaging–Based Chatbot
Braddock, W. R. T., Ocasio, M. A., Comulada, W. S., Mandani, J., & Fernandez, M. I. (2023) · JMIR Research Protocols · doi:10.2196/42983 · Cited by 21
A case of purulent gonococcal arthritis
Vidaurrazaga, M. M., & Perlman, D. C. (2019) · IDCases · doi:10.1016/j.idcr.2019.e00662 · Cited by 21
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV
Coyle, R. P., Morrow, M., Coleman, S. S., Gardner, E. M., Zheng, J., Ellison, L., Bushman, L. R., Kiser, J. J., MaWhinney, S., Anderson, P. L., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa070 · Cited by 21
Socio-behavioral correlates of pre-exposure prophylaxis use and correct adherence in men who have sex with men in West Africa
Eubanks, A., Coulibaly, B., Keïta, B. D., Anoma, C., Dah, T. T. E., Mensah, E., Kaba, S., Lokrou, K. J., Ouedraogo, F. R., Badjassim, A. M., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-14211-8 · Cited by 21
A Systematic Review and Narrative Synthesis of Factors Affecting Pre-exposure Prophylaxis Willingness Among Black Women for HIV Prevention
Sims-Haynes, A., Markham, C. M., Schick, V., Suchting, R., Parthasarathy, N., Choudhury, S., & Hill, M. J. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04491-z · Cited by 25
High HIV risk and syndemic burden regardless of referral source among MSM screening for a PrEP demonstration project in Toronto, Canada
Wilton, J., Noor, S. W. B., Schnubb, A., Lawless, J., Hart, T. A., Grennan, T., Fowler, S., Maxwell, J., & Tan, D. H. S. (2018) · BMC Public Health · doi:10.1186/s12889-018-5180-8 · Cited by 20
Tennessee Healthcare Provider Practices, Attitudes, and Knowledge Around HIV Pre-Exposure Prophylaxis
Moore, E., Kelly, S. G., Alexander, L. R., Luther, P., Cooper, R. L., Rebeiro, P. F., Zuckerman, A. D., Hargreaves, M. K., Bourgi, K., Schlundt, D. G., et al. (2020) · Journal of Primary Care & Community Health · doi:10.1177/2150132720984416 · Cited by 23
Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study
Marins, L. M. S., Torres, T. S., Luz, P. M., Moreira, R. I., Leite, I. C., Hoagland, B., Kallas, E. G., Madruga, J. V., Grinsztejn, B. G. J., Veloso, V. G., et al. (2021) · International Journal of STD & AIDS · doi:10.1177/09564624211031787 · Cited by 20
Association of Race and Other Social Determinants of Health With HIV Pre-Exposure Prophylaxis Use: A County-Level Analysis Using the PrEP-to-Need Ratio
Doherty, R., Walsh, J. L., Quinn, K. G., & John, S. A. (2022) · AIDS Education and Prevention · doi:10.1521/aeap.2022.34.3.183 · Cited by 20
Achieving the “Ending the HIV Epidemic in the U.S.” incidence reduction goals among at-risk populations in the South
Hamilton, D. T., Hoover, K. W., Smith, D. K., Delaney, K. P., Wang, L. Y., Li, J., Hoyte, T., Jenness, S. M., & Goodreau, S. M. (2023) · BMC Public Health · doi:10.1186/s12889-023-15563-5 · Cited by 20
What Community-Based HIV Prevention Organizations Say About Their Role in Biomedical HIV Prevention
Smith, D. K., Maier, E., Betts, J. E., Gray, S. C., Kolodziejski, B., & Hoover, K. W. (2016) · AIDS Education and Prevention · doi:10.1521/aeap.2016.28.5.426 · Cited by 20
Evaluating Testing Strategies for Identifying Youths With HIV Infection and Linking Youths to Biomedical and Other Prevention Services
Miller, R. L., Boyer, C. B., Chiaramonte, D. M., Lindeman, P. T., Chutuape, K. S., Walker, B. C., Kapogiannis, B. G., Wilson, C. M., & Fortenberry, J. D. (2017) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2017.0105 · Cited by 20
Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin – A multicentre, cross-sectional survey
Werner, R. N., Gaskins, M. D., Ahrens, J., Jessen, H. K., Kutscha, F., Mosdzen, R., Osswald, W., Sander, D., Schellberg, S., Schwabe, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204067 · Cited by 20
Pre-Exposure Prophylaxis (PrEP) Use is Associated With Health Risk Behaviors Among Moderate- and Heavy-Drinking MSM
Luehring‐Jones, P., Palfai, T. P., Tahaney, K. D., Maisto, S. A., & Simons, J. S. (2019) · AIDS Education and Prevention · doi:10.1521/aeap.2019.31.5.452 · Cited by 20
Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol
Ming, K., Shrestha, I., Vazquez, A., Wendelborn, J., Jimenez, V., Lisha, N. E., Neilands, T. B., Scott, H. M., Liu, A., Steward, W. T., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040734 · Cited by 20
From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications
Cancio-Suárez, M. R., Díaz-Álvarez, J., Ron, R., Martínez‐Sanz, J., Villar, S. S., Moreno, S., & Sánchez‐Conde, M. (2023) · Pathogens · doi:10.3390/pathogens12070924 · Cited by 20
Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review
Fields, S. D., & Tung, E. L. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00384-5 · Cited by 19
Evaluation der Einführung der HIV-Präexpositionsprophylaxe als Leistung der gesetzlichen Krankenversicherung (EvE‑PrEP)
Schmidt, D., Kollan, C., Schewe, K., Hanhoff, N., Rüsenberg, R., Friebe, M., Schikowski, T., Schink, S. B., Marcus, U., Koppe, U., et al. (2023) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-023-03733-0 · Cited by 19
Incidence of sexually transmitted infections and association with behavioural factors: Time‐to‐event analysis of a large pre‐exposure prophylaxis ( PrEP ) cohort
Hovaguimian, F., Kouyos, R. D., Kusejko, K., Schmidt, A. J., TARR, P. E., Bernasconi, E., Braun, D. L., Calmy, A., Notter, J., Stoeckle, M. P., et al. (2023) · HIV Medicine · doi:10.1111/hiv.13543 · Cited by 19
Improving Delivery and Use of HIV Pre-Exposure Prophylaxis in the US: A Systematic Review of Implementation Strategies and Adjunctive Interventions
Merle, J. L., Benbow, N., Li, D. H., Zapata, J. P., Queiroz, A. A. F. L. N., Zamantakis, A., McKay, V., Keiser, B., Villamar, J. A., Mustanski, B. S., et al. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04331-0 · Cited by 22
Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
Anderson, P. L., Reirden, D. H., & Castillo‐Mancilla, J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001105 · Cited by 20
A Behavioral Cascade of HIV Seroadaptation Among US Men Who Have Sex with Men in the Era of PrEP and U = U
Goodreau, S. M., Maloney, K. M., Sanchez, T., Morris, M., Janulis, P. F., & Jenness, S. M. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03266-0 · Cited by 19
Is knowledge of HIV status associated with sexual behaviours? A fixed effects analysis of a female sex worker cohort in urban Uganda
Ortblad, K. F., Musoke, D. K., Ngabirano, T., Salomon, J. A., Haberer, J. E., McConnell, M. A., Oldenburg, C. E., & Bärnighausen, T. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25336 · Cited by 18
Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men – a double-blind randomised controlled trial protocol
Lau, A., Kong, F. Y. S., Fairley, C. K., Donovan, B. J., Chen, M. Y., Bradshaw, C. S., Boyd, M. A., Amin, J., Timms, P., Tabrizi, S., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-016-2125-7 · Cited by 18
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate
Brooks, K. M., Ibrahim, M. E., Castillo‐Mancilla, J., MaWhinney, S., Alexander, K., Tilden, S. G., Kerr, B. J., Ellison, L., McHugh, C., Bushman, L. R., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz187 · Cited by 18
Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT
Velloza, J., Bacchetti, P., Hendrix, C. W., Murnane, P. M., Hughes, J. P., Li, M., Curlin, M. E., Holtz, T. H., Mannheimer, S., Marzinke, M. A., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002128 · Cited by 18
Brief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention
Epps, P. V., Wilson, B. M., Garner, W., Beste, L. A., Maier, M. M., & Ohl, M. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002186 · Cited by 18
Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials
Arrington‐Sanders, R., Wilson, C. M., Perumean‐Chaney, S. E., Patki, A., & Hosek, S. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001901 · Cited by 18
HIV Oral Pre-exposure Prophylaxis Effectiveness, Adherence, and Discontinuation in an Italian Multicentric Access Program: ItaPrEP Study
Mazzotta, V., Caruso, E., Tavelli, A., Esvan, R., Lanini, S., Micheli, G., Moschese, D., Bona, A. D., Mattioli, S., Calzavara, D., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf539 · Cited by 17
Lessons from a decade of voluntary medical male circumcision implementation and their application to HIV pre-exposure prophylaxis scale up
Reed, J. B., Patel, R. R., & Baggaley, R. C. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418787896 · Cited by 18
Context matters: PrEP adherence is associated with sexual behavior among HIV serodiscordant couples in East Africa
Haberer, J., Ngure, K., Muwonge, T., Mugo, N., Katabira, E., Heffron, R., Musinguzi, N., Bangsberg, D., Celum, C., & Baeten, J. (2017) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001548 · Cited by 18
Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project
Vaccher, S. J., Marzinke, M. A., Templeton, D. J., Haire, B. G., Ryder, N., McNulty, A. M., Foster, R., Grulich, A. E., Zablotska, I., the PRELUDE Study Team, et al. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2353-5 · Cited by 19
Emtricitabine triphosphate in dried blood spots is a predictor of viral suppression in HIV infection and reflects short-term adherence to antiretroviral therapy
Frasca, K., Morrow, M., Coyle, R. P., Coleman, S. S., Ellison, L., Bushman, L. R., Kiser, J. J., Zheng, J., MaWhinney, S., Anderson, P. L., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky559 · Cited by 17
A Demedicalized Model to Provide PrEP in a Sexual Health Clinic
Ramchandani, M. S., Berzkalns, A., Cannon, C. A., Dombrowski, J. C., Ocbamichael, N., Khosropour, C. M., Barbee, L. A., & Golden, M. R. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003005 · Cited by 17
Pharmacology supports on-demand PrEP
Glidden, D. V., Anderson, P. L., & Grant, R. M. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30114-x · Cited by 17
A Decade of HIV Preexposure Prophylaxis (PrEP): Overcoming Access Barriers in the United States Through Expanded Delivery
Jackson, K. J., McCoy, S. I., & White, D. A. E. (2023) · Public Health Reports · doi:10.1177/00333549231208487 · Cited by 17
Factors Associated with Planned Future Use of PrEP in the Next 3 Months and Likelihood to Use PrEP Among Black Cisgender HIV-negative Women in Texas
Sophus, A. I., Mitchell, J. W., Barroso, J., & Sales, J. M. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-04188-9 · Cited by 16
Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort
van den Elshout, M. A. M., Wijstma, E. S., Boyd, A. C., Jongen, V. W., Coyer, L., Anderson, P. L., Davidovich, U., de Vries, H. J. C., Prins, M., van der Loeff, M. F. S., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004328 · Cited by 17
Psychometric evaluation of the Condom Barriers and Motivations Scale (CBMS)
Golub, S. A., & Gamarel, K. E. (2016) · Journal of Behavioral Medicine · doi:10.1007/s10865-016-9815-x · Cited by 16
The Acceptability of Pre-Exposure Prophylaxis: Beliefs of Health-Care Professionals Working in Sexually Transmitted Infections Clinics and HIV Treatment Centers
Bil, J. P., Hoornenborg, E., Prins, M., Hogewoning, A. A., Lima, F. D. G., de Vries, H. J. C., & Davidovich, U. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00005 · Cited by 16

Authors: Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., Liegler, T., Rawlings, M. K., Trainor, N., Blue, R. W., Estrada, Y., Coleman, M. E., Cardenas, G., Feaster, D. J., Grant, R., Philip, S. S., Elion, R., Buchbinder, S., & Kolber, M. A.
Affiliations: University of California, San Francisco (US)
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora
Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida
National Institutes of Health (US)
DF/Net Research, Inc, Seattle, Washington
San Francisco Department of Public Health (US)
University of Michigan (US)
Gilead Sciences (United States) (US)
University of Miami (US)
Whitman-Walker Health (US)
Gladstone Institutes (US)
George Washington University (US)
Corresponding author: Liu, Albert Y.
ORCID: Liu, Albert Y.
Cohen, Stephanie E.
Vittinghoff, Eric
Anderson, Peter L.
Bacon, Oliver
Chege, Wairimu
Matheson, Tim
Amico, K. Rivet
Rawlings, M. Keith
Estrada, Yannine
Coleman, Megan E.
Feaster, Daniel J.
Grant, Robert
Philip, Susan S.
Buchbinder, Susan
Kolber, Michael A.
Venue: JAMA Internal Medicine
Publisher: American Medical Association (AMA)
Published: 2016-01-01
Volume: 176
Issue: 1
Pages: 75
ISSN: 2168-6106 (ISSN-L)
DOI: 10.1001/jamainternmed.2015.4683
PMC: PMC5042323
OpenAlex: W2173821673
Cited by: 602
References: 46
Citations by year: 2026: 12 · 2025: 29 · 2024: 42 · 2023: 45 · 2022: 57 · 2021: 47 · 2020: 68 · 2019: 87 · 2018: 83 · 2017: 71 · 2016: 57
FWCI: 55.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA Internal Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institutes of Health
National Institute of Mental Health (R01MH095628)
National Institute of Allergy and Infectious Diseases (R01AI118575, UM1AI069496, P30AI027763, P30AI073961)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: pre-exposure prophylaxis, HIV prevention, men who have sex with men, transgender women, tenofovir disoproxil fumarate, emtricitabine, PrEP adherence, sexually transmitted infections, sexual partners, HIV acquisition, HIV testing, community health centers, STD clinics, housing stability
MeSH terms: Tenofovir, Assessment of Medication Adherence, Adenine, Adolescent, Adult, Bisexuality, Chlamydia Infections, Community Health Services, District of Columbia, Female, Florida, Gonorrhea, Humans, Male, Middle Aged, Organophosphates, Prospective Studies, San Francisco, Sexual Behavior, Syphilis, HIV Infections, Drug Monitoring, Homosexuality, Male, Anti-HIV Agents, Unsafe Sex, Medication Adherence, Young Adult, Reproductive Health, Transgender Persons, Pre-Exposure Prophylaxis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks